1. Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate‐grade or high‐grade liposarcoma. Issue 23 (18th August 2017) Authors: Samuels, Brian L.; Chawla, Sant P.; Somaiah, Neeta; Staddon, Arthur P.; Skubitz, Keith M.; Milhem, Mohammed M.; Kaiser, Pamela E.; Portnoy, David C.; Priebat, Dennis A.; Walker, Mark S.; Stepanski, Edward J. Journal: Cancer Issue: Volume 123:Issue 23(2017) Page Start: 4640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗